TY - JOUR
T1 - What should selective cardiometabolic prevention programmes in European primary care look like?
T2 - A consensus-based design by the SPIMEU group
AU - Kral, Norbert
AU - de Waard, Anne-Karien M.
AU - Schellevis, Francois G.
AU - Korevaar, Joke C.
AU - Lionis, Christos
AU - Carlsson, Axel C.
AU - Sonderlund, Anders Larrabee
AU - Sondergaard, Jens
AU - Larsen, Lars Bruun
AU - Hollander, Monika
AU - Thilsing, Trine
AU - Angelaki, Agapi
AU - de Wit, Niek J.
AU - Seifert, Bohumil
PY - 2019/7
Y1 - 2019/7
N2 - Background: Selective prevention of cardiometabolic diseases (CMD)-that is, preventive measures specifically targeting the high-risk population-may represent the most effective approach for mitigating rising CMD rates. Objectives: To develop a universal concept of selective CMD prevention that can guide implementation within European primary care. Methods: Initially, 32 statements covering different aspects of selective CMD prevention programmes were identified based on a synthesis of evidence from two systematic literature reviews and surveys conducted within the SPIMEU project. The Rand/UCLA appropriateness method (RAM) was used to find consensus on these statements among an international panel consisting of 14 experts. Before the consensus meeting, statements were rated by the experts in a first round. In the next step, during a face-to-face meeting, experts were provided with the results of the first rating and were then invited to discuss and rescore the statements in a second round. Results: In the outcome of the RAM procedure, 28 of 31 statements were considered appropriate and three were rated uncertain. The panel deleted one statement. Selective CMD prevention was considered an effective approach for preventing CMD and a proactive approach was regarded as more effective compared to case-finding alone. The most efficient method to implement selective CMD prevention systematically in primary care relies on a stepwise approach: initial risk assessment followed by interventions if indicated. Conclusion: The final set of statements represents the key characteristics of selective CMD prevention and can serve as a guide for implementing selective prevention actions in European primary care.
AB - Background: Selective prevention of cardiometabolic diseases (CMD)-that is, preventive measures specifically targeting the high-risk population-may represent the most effective approach for mitigating rising CMD rates. Objectives: To develop a universal concept of selective CMD prevention that can guide implementation within European primary care. Methods: Initially, 32 statements covering different aspects of selective CMD prevention programmes were identified based on a synthesis of evidence from two systematic literature reviews and surveys conducted within the SPIMEU project. The Rand/UCLA appropriateness method (RAM) was used to find consensus on these statements among an international panel consisting of 14 experts. Before the consensus meeting, statements were rated by the experts in a first round. In the next step, during a face-to-face meeting, experts were provided with the results of the first rating and were then invited to discuss and rescore the statements in a second round. Results: In the outcome of the RAM procedure, 28 of 31 statements were considered appropriate and three were rated uncertain. The panel deleted one statement. Selective CMD prevention was considered an effective approach for preventing CMD and a proactive approach was regarded as more effective compared to case-finding alone. The most efficient method to implement selective CMD prevention systematically in primary care relies on a stepwise approach: initial risk assessment followed by interventions if indicated. Conclusion: The final set of statements represents the key characteristics of selective CMD prevention and can serve as a guide for implementing selective prevention actions in European primary care.
KW - Selective prevention
KW - cardiometabolic disease
KW - consensus development
KW - general practice
KW - primary care
UR - http://www.scopus.com/inward/record.url?scp=85070869227&partnerID=8YFLogxK
U2 - 10.1080/13814788.2019.1641195
DO - 10.1080/13814788.2019.1641195
M3 - Article
C2 - 31411091
SN - 1381-4788
VL - 25
SP - 101
EP - 108
JO - European Journal of General Practice
JF - European Journal of General Practice
IS - 3
ER -